Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis
Brain Sciences · 25.02.2025 · 15 (3) · 241
DOI: 10.3390/brainsci15030241 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 25.02.2025. Verfasst von Silvia Demiri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Multiple system atrophy (MSA) presents a challenging diagnosis due to its clinical overlap with other neurodegenerative disorders, especially other α-synucleinopathies. The main purpose of this systematic review and meta-analysis was to assess neurofilament light chain (NfL) differences in the CSF and blood of patients with MSA versus the healthy control group (HC), patients with Parkinson’s disease (PD) and patients with Lewy body dementia (LBD). Secondarily, the diagnostic metrics of CSF and circulating NfL in MSA versus HC, PD, LBD, progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) were discussed.
Methods
MEDLINE and EMBASE were thoroughly searched for relevant case-control studies. Standardized mean differences (SMDs) were calculated separately for CSF and blood NfL per comparison. Statistical heterogeneity was assessed based on the Q and I^2 statistics.
Results
Twenty-five relevant studies were retrieved. Quantitative syntheses revealed elevated CSF and circulating NfL levels in individuals with MSA versus HC [SMD = 1.80 (95%CI = 1.66, 1.94) and SMD = 2.00 (95%CI = 1.36, 2.63), respectively] versus PD [SMD = 1.65 (95%CI = 1.26, 2.03) and SMD = 1.63 (95%CI = 0.84, 2.43), respectively] as well as versus LBD [SMD = 1.17, (95%CI = 0.71, 1.63) and SMD = 0.65 (95%CI = 0.30, 1.00), respectively]. Diagnostic accuracy was outstanding for CSF and blood NfL in MSA versus HC and PD, and it was moderate in MSA versus LBD. On the other hand, it was suboptimal in MSA vs. PSP and CBD.
Conclusions
Both CSF and circulating NfL levels are elevated in MSA compared to HC, PD and LBD. To achieve optimal diagnostic properties, further work is required in the standardization of processes and the establishment of reference NfL intervals and/or thresholds.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
- Department of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, 41100 Larissa, Greece.
ORCID-Profile: Silvia Demiri, Efthimios Dardiotis, Ioannis Liampas
Zitieren
APA
Demiri, S., Veltsista, D., Siokas, V., Spiliopoulos, K. C., Tsika, A., Stamati, P., Chroni, E., Dardiotis, E., & Liampas, I. (2025). Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis. Brain Sciences, 15(3), 241. https://doi.org/10.3390/brainsci15030241
Vancouver
Demiri S, Veltsista D, Siokas V, Spiliopoulos KC, Tsika A, Stamati P, et al. Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis. Brain Sciences. 2025;15(3):241. doi:10.3390/brainsci15030241
BibTeX
@article{Demiri2025,
author = {Demiri, Silvia and Veltsista, Dimitra and Siokas, Vasileios and Spiliopoulos, Kanellos C and Tsika, Antonia and Stamati, Polyxeni and Chroni, Elisabeth and Dardiotis, Efthimios and Liampas, Ioannis},
title = {Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis},
journal = {Brain Sciences},
year = {2025},
volume = {15},
number = {3},
pages = {241},
doi = {10.3390/brainsci15030241}
}
EUVIMED